Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
$1.75B |
| 2 |
NVIDIA
NVDA
|
$1.34B |
| 3 |
Capital One
COF
|
$1.16B |
| 4 |
Apple
AAPL
|
$1.01B |
| 5 |
Amazon
AMZN
|
$813M |
Top Sells
| 1 |
DFS
Discover Financial Services
DFS
|
$1.09B |
| 2 |
Palantir
PLTR
|
$777M |
| 3 |
Coca-Cola
KO
|
$496M |
| 4 |
Qualcomm
QCOM
|
$469M |
| 5 |
Applovin
APP
|
$390M |
Sector Composition
| 1 | Technology | 32.48% |
| 2 | Financials | 14.03% |
| 3 | Consumer Discretionary | 10.52% |
| 4 | Healthcare | 9.35% |
| 5 | Communication Services | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NTWO
4051
Newbury Street II Acquisition Corp Class A Ordinary Shares
NTWO
| $104K | ﹤0.01% |
10,095
| – | – |
|
4052
Tandy Leather Factory
TLF
$24.8M
| $104K | ﹤0.01% |
33,458
+800
| +2% | +$2.48K |
|
4053
Cellectar Biosciences
CLRB
$15.9M
| $103K | ﹤0.01% |
14,439
-342
| -2% | -$2.43K |
|
4054
Iron Horse Acquisitions Corp
IROH
$22.1M
| $103K | ﹤0.01% |
10,080
| – | – |
|
4055
XBP Global Holdings, Inc. Common Stock
XBP
$71.8M
| $102K | ﹤0.01% |
110,167
-113
| -0.1% | -$105 |
|
4056
ProPhase Labs
PRPH
$14.7M
| $101K | ﹤0.01% |
259,063
+31,369
| +14% | +$12.3K |
|
|
JCTC
4057
Jewett-Cameron Trading
JCTC
$12.8M
| $101K | ﹤0.01% |
26,805
+643
| +2% | +$2.42K |
|
|
FOXX
4058
Foxx Development Holdings Inc. Common Stock
FOXX
$39.3M
| $101K | ﹤0.01% |
18,750
+872
| +5% | +$4.69K |
|
4059
LiqTech
LIQT
$20.3M
| $100K | ﹤0.01% |
61,996
+254
| +0.4% | +$412 |
|
|
XNET
4060
Xunlei
XNET
$479M
| $100K | ﹤0.01% |
24,768
| – | – |
|
4061
Metalpha Technology Holding
MATH
$130M
| $100K | ﹤0.01% |
+31,314
| New | +$100K |
|
4062
ProQR Therapeutics
PRQR
$258M
| $99.6K | ﹤0.01% |
48,822
| – | – |
|
|
MTLS
4063
Materialise
MTLS
$292M
| $99K | ﹤0.01% |
17,527
| – | – |
|
4064
Lyra Therapeutics
LYRA
$11.3M
| $98.5K | ﹤0.01% |
10,986
-9,334
| -46% | -$83.6K |
|
4065
Aterian
ATER
$9.76M
| $98.1K | ﹤0.01% |
59,110
-386
| -0.6% | -$641 |
|
4066
Carisma Therapeutics
CARM
$16.8M
| $98.1K | ﹤0.01% |
250,495
+6,154
| +3% | +$2.41K |
|
4067
Rani Therapeutics
RANI
$24.1M
| $97.9K | ﹤0.01% |
190,557
-5,660
| -3% | -$2.91K |
|
4068
Flora Growth
FLGC
$13M
| $97.8K | ﹤0.01% |
4,322
+77
| +2% | +$1.74K |
|
|
SORA
4069
AsiaStrategy Ordinary Shares
SORA
$143M
| $96.4K | ﹤0.01% |
+15,111
| New | +$96.4K |
|
4070
Allurion Technologies
ALUR
$17.3M
| $96K | ﹤0.01% |
39,520
-1,374
| -3% | -$3.34K |
|
4071
Cyclerion Therapeutics
CYCN
$7.11M
| $95.3K | ﹤0.01% |
32,735
+1,132
| +4% | +$3.3K |
|
4072
FAT Brands
FAT
$33.6M
| $94.4K | ﹤0.01% |
39,633
-3,851
| -9% | -$9.17K |
|
4073
Worksport
WKSP
$22.6M
| $94.1K | ﹤0.01% |
33,259
+3,338
| +11% | +$9.45K |
|
4074
X4 Pharmaceuticals
XFOR
$78.6M
| $93.4K | ﹤0.01% |
49,146
-71,510
| -59% | -$136K |
|
|
BDMD
4075
Baird Medical Investment Holdings Ltd Ordinary Share
BDMD
$85.5M
| $93.2K | ﹤0.01% |
25,442
+9,511
| +60% | +$34.9K |
|